[go: up one dir, main page]

AR075834A1 - Dispositivo para la administracion intranasal - Google Patents

Dispositivo para la administracion intranasal

Info

Publication number
AR075834A1
AR075834A1 ARP100100795A ARP100100795A AR075834A1 AR 075834 A1 AR075834 A1 AR 075834A1 AR P100100795 A ARP100100795 A AR P100100795A AR P100100795 A ARP100100795 A AR P100100795A AR 075834 A1 AR075834 A1 AR 075834A1
Authority
AR
Argentina
Prior art keywords
intranasal administration
devices
oxygen
ampules
bulbs
Prior art date
Application number
ARP100100795A
Other languages
English (en)
Inventor
Roger Whiting
Ramachandran Thirucote
Original Assignee
Roxro Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roxro Pharma Inc filed Critical Roxro Pharma Inc
Publication of AR075834A1 publication Critical patent/AR075834A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A61M11/007—Syringe-type or piston-type sprayers or atomisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/16—Holders for containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00—Ancillary equipment
    • A61M2209/06—Packaging for specific medical equipment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mechanical Engineering (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Ampolletas y dispositivos que contienen una solucion de ketorolac para administracion intranasal y un espacio de cabeza que no comprende más de aproximadamente 10% v/v de oxígeno. También procesos para preparar las ampolletas y dispositivos. Las ampolletas y dispositivos opcionalmente se pueden almacenar en un sachet impermeable al oxígeno.
ARP100100795A 2009-03-13 2010-03-12 Dispositivo para la administracion intranasal AR075834A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/404,250 US8277781B2 (en) 2009-03-13 2009-03-13 Device for intranasal administration

Publications (1)

Publication Number Publication Date
AR075834A1 true AR075834A1 (es) 2011-04-27

Family

ID=42235790

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100100795A AR075834A1 (es) 2009-03-13 2010-03-12 Dispositivo para la administracion intranasal

Country Status (12)

Country Link
US (3) US8277781B2 (es)
EP (1) EP2405964A1 (es)
JP (1) JP2012520140A (es)
KR (1) KR20110127747A (es)
CN (1) CN102438686A (es)
AR (1) AR075834A1 (es)
AU (1) AU2010224068A1 (es)
BR (1) BRPI1009191A2 (es)
CA (1) CA2760563A1 (es)
RU (1) RU2011140749A (es)
TW (1) TW201043277A (es)
WO (1) WO2010105042A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103099735A (zh) * 2011-11-14 2013-05-15 江苏省药物研究所有限公司 用于酮咯酸氨丁三醇喷雾剂的内胆式药瓶
CN103655472A (zh) * 2012-09-14 2014-03-26 南京康来福医药科技有限公司 一种酮咯酸氨丁三醇鼻腔喷雾剂及制备方法
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
WO2018071452A1 (en) 2016-10-11 2018-04-19 Growblox Life Sciences L.L.C. Cannabinoid-containing complex mixtures for the treatment of neurodegenerative diseases
WO2018144637A1 (en) 2017-02-01 2018-08-09 Growblox Life Sciences L.L.C. Cannabinoid-containing complex mixtures for the treatment of mast cell-associated or basophil-mediated inflammatory disorders
JP2020520966A (ja) 2017-05-22 2020-07-16 ジービーエス グローバル バイオファーマ，インコーポレイテッド Ｔｒｐｖ１を標的にするミルセン及びカンナビノイド含有組成物
US11053037B2 (en) 2017-10-06 2021-07-06 Hikma Pharmaceuticals Usa Inc. System and method for purging oxygen from medical vials
CA3100947A1 (en) 2018-05-22 2019-11-28 Gbs Global Biopharma, Inc. Cannabinoids and/or terpenes for use in trpv1 modulation
US20200405657A1 (en) 2019-06-28 2020-12-31 Gbs Global Biopharma, Inc. Treatment of pain using allosteric modulator of trpv1
US12098018B2 (en) * 2021-01-15 2024-09-24 Oyster Point Pharma, Inc. Nesting structures for storage, transport, and assembly of drug dispensers and containers
USD995753S1 (en) * 2021-02-16 2023-08-15 Joanne M. Tobiasz-Dey Nasal spray device

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150744A (en) 1976-02-27 1979-04-24 Smith & Nephew Pharmaceuticals Ltd. Packaging
US4089969A (en) 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
CA1291036C (en) 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
NZ222907A (en) 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
US4778810A (en) 1987-01-08 1988-10-18 Nastech Pharmaceutical Co., Inc. Nasal delivery of caffeine
US4943587A (en) 1988-05-19 1990-07-24 Warner-Lambert Company Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl residues and their use for cyclooxygenase and 5-lipoxygenase inhibition
US4885287A (en) 1988-08-09 1989-12-05 University Of Kentucky Research Foundation Novel method of administering aspirin and dosage forms containing same
US4994439A (en) 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
US5143731A (en) 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
IT1250691B (it) 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
GB2315673A (en) 1996-08-01 1998-02-11 Merck & Co Inc Treatment of migraine
US6090368A (en) 1998-03-03 2000-07-18 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Pharmaceutical compositions for intranasal spray administration of ketorolac tromethamine
US6390291B1 (en) 1998-12-18 2002-05-21 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US20020061281A1 (en) 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
DE10118306A1 (de) 2001-04-12 2002-10-17 Bayer Ag Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation
US20080220107A1 (en) 2002-09-03 2008-09-11 Pharmacure Health Care Ab Nasal spray apparatus
JP4869927B2 (ja) 2003-08-04 2012-02-08 アレックザ ファーマシューティカルズ， インコーポレイテッド 薬物送達デバイスのための基材および調製方法および使用
CA2587792C (en) 2004-12-23 2010-07-06 Roxro Pharma, Inc. Therapeutic compositions for intranasal administration of ketorolac
US7918718B2 (en) * 2005-05-31 2011-04-05 Slagteriernes Forskningsinstitut Method and facility for automatically determining quality characteristics of a carcass on a slaughterline
US20070062162A1 (en) * 2005-09-19 2007-03-22 Martin Lehmann Method and apparatus for cleaning containers to be sealed and containing a filler from oxygen gas
US20090011051A1 (en) * 2006-09-28 2009-01-08 Roth Mark B Methods, Compositions and Articles of Manufacture for HIF Modulating Compounds

Also Published As

Publication number Publication date
KR20110127747A (ko) 2011-11-25
US20150314084A1 (en) 2015-11-05
US20130000634A1 (en) 2013-01-03
CN102438686A (zh) 2012-05-02
CA2760563A1 (en) 2010-09-16
WO2010105042A1 (en) 2010-09-16
US20100233099A1 (en) 2010-09-16
US8277781B2 (en) 2012-10-02
BRPI1009191A2 (pt) 2016-03-01
RU2011140749A (ru) 2013-04-20
TW201043277A (en) 2010-12-16
EP2405964A1 (en) 2012-01-18
AU2010224068A1 (en) 2011-11-03
JP2012520140A (ja) 2012-09-06

Similar Documents

Publication Publication Date Title
AR075834A1 (es) Dispositivo para la administracion intranasal
CO6900149A2 (es) Una composición farmacéutica que comprende los fitocanabinoides canabidivarina (cbdv) y canabidiol (cbd)
MX2012001308A (es) Dispositivo para el cuidado bucal.
CR20150174A (es) Composición esterilizada que comprende al menos un ácido hialuronico y ascorbil fosfato de magnesio
MX2012008717A (es) Composiciones para el cuidado oral.
SV2010003744A (es) Composicion farmaceutica que comprende una sal de estroncio, vitamina d y una ciclodextrina
ECSP13012431A (es) Combinación del compuesto glyt1 con antipsicóticos
AR072509A1 (es) Procedimientos, aparatos y productos de programas informaticos para proporcionar informacion
ECSP13012667A (es) Compuestos de triazolopiridina
EA201200484A1 (ru) Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином
BR112014006248A2 (pt) compostos de triazolopiridina como inibidores de pde10a
BR112014026828A2 (pt) compostos de triazolo como inibidores de pde10
CL2012003523A1 (es) Método para la preparación de una composición farmacéutica que contiene un portador de oxígeno termoestable; composicion farmaceutica que contiene un portador de oxigeno altamente purificado y termoestable.
EP2752233A4 (en) OXYGEN ABSORPTION AGENT AND OXYGEN ABSORBING PACKING THEREWITH
AR084564A1 (es) Sistema aromatizador de aire
EP2976446A4 (en) PORTABLE HYDROGEN AND OXYGEN SUPPLY SYSTEM
BR112015012453A8 (pt) métodos e usos para sincronizar o tempo de ovulação e de inseminação em uma leitoa
AR082215A1 (es) Composicion farmaceutica agradable al paladar
PE20121537A1 (es) Combinacion de teobromina con un descongestivo
BR112013005993A2 (pt) unidade de fornecimento de fluoreto de hidrogênio
MX374994B (es) Carbonato de sodio anhidro que tiene un bajo contenido de poros.
AR066975A1 (es) Envase
AR088870A1 (es) Geles para el cuidado oral
CL2012002461A1 (es) Empaque que contiene una pluralidad de artículos absorbentes desechables y que comprende un precorte y un gráfico de un personaje en combinación con el precorte.
WO2013060672A3 (en) A cooling device comprising a storage tank wherein the liquid stored therein is sterilized

Legal Events

Date Code Title Description
FB Suspension of granting procedure